2型糖尿病及其微血管并发症患者血清miR-342-5p和miR-423-5p水平测定及临床意义
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

国家自然科学基金(81271904); 国家重大科学仪器设备开发专项(2012YQ03026109);南京军区总医院院课题(2014043)。


Study on levels of serum miR-342-5p and miR-423-5p in type 2 diabetes patients with or without microvascular complications and their clinical significance
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    摘要:目的:检测2型糖尿病(T2DM)及其微血管并发症患者血清miR-342-5p、miR-423-5p及氧化脂蛋白水平,分析其潜在的临床意义。 方法:用实时荧光定量PCR检测50例T2DM、T2DM微血管并发症患者及体检健康者血清 miR-342-5p和miR-423-5p表达水平;ELISA法检测其ox-LDL,ox-Lp(a),β2-GPⅠ-ox-LDL,β2-GPⅠ-Lp(a)的含量;生化分析仪测定相关生化指标。 结果:与健康对照组血清miR-342-5p和miR-423-5p表达水平 [分别为0.144(0.027,0.487)fmol/L;1.480(0.676,2.580) fmol/L]比较,T2DM 患者[0.234(0.103,1.241)fmol/L(U=779,P<0.01); 3.398(1.742,7.351)fmol/L(U=606,P<0.01)]和T2DM微血管并发症患者[0.300(0.102,2.760)fmol/L(U=731,P<0.01); 3.886(2.021,9.430)fmol/L(U=488,P<0.01)]表达水平显著上升。miR-342-5p和miR-423-5p对T2DM患者诊断的ROC曲线下面积(AUCROC)分别为0.688(95% CI:0.586~0.791)和0.758(95% CI:0.664~0.851),对T2DM微血管并发症患者分别为0.702(95% CI:0.600~0.803)和0.801(95%CI:0.716~0.886); T2DM和T2DM微血管并发症患者ox-LDL、ox-Lp(a)、β2-GPⅠ-ox-LDL、β2-GPⅠ-Lp(a)水平亦显著高于健康对照组(P均<0.05)。Spearman秩相关分析显示,miR-342-5p和miR-423-5p与FPG、ox-LDL、ox-Lp(a)、β2-GPⅠ-ox-LDL、β2-GPⅠ-Lp(a)呈显著正相关(P均<0.05)。 结论:miR-342-5p和miR-423-5p可能作为T2DM及其微血管并发症的辅助诊断指标。

    Abstract:

    Abstract:Objective:To determine the serum levels of miR-342-5p and miR-423-5p in type 2 diabetes (T2DM) patients with or without microvascular complications, and explore their associations with oxidized lipoprotein and other biochemical parameters in serum. Methods:The serum levels of miR-342-5p and miR-423-5p were examined in 50 T2DM patients, 50 T2DM patients with microvascular complications and 50 healthy controls using quantitative real-time PCR (qRT-PCR). The concentrations of ox-LDL, ox-Lp(a), β2-GPⅠ-ox-LDL and β2-GPⅠ-Lp(a) were also measured in the serum samples of the same cohort using enzyme linked immunosorbent assay (ELISA). The levels of fasting blood glucose, triglycerides, cholesterol, high density lipoprotein, low density lipoprotein and others biochemical parameters were determined by biochemical analyzer. Results:The data of qRT-PCR showed that the concentrations of miR-342-5p and miR-423-5p were 0.144 (0.027, 0.487) fmol/L and 1.480 (0.676, 2.580) fmol/L in healthy controls which were significant higher than those of T2DM patients [miR-342-5p: 0.234(0.103,1.241) fmol/L (U=779,P<0.01); miR-423-5p: 3.398(1.742,7.351) fmol/L(U=606, P<0.01), respectively] and T2DM patients with microvascular complications [miR-342-5p: 0.300 (0.102, 2.760) fmol/L (U=731, P<0.01); miR-423-5p: 3.886(2.021, 9.430) fmol/L (U=488, P<0.01), respectively]. ROC curve analysis results showed that the area of under ROC curve (AUCROC) of miR-342-5p and miR-423-5p were 0.688 (95%CI: 0.586 to 0.803) and 0.702 (95%CI: 0.600 to 0.803) for T2DM patients, and 0.758 (95% CI: 0.664 to 0.851) and 0.801 (95% CI: 0.716 to 0.886) for T2DM patients with microvascular complications, respectively. The ELISA results showed the concentrations of FPG, ox-LDL, ox-Lp (a), β2-GPⅠ-ox-LDL and β2-GPⅠ-Lp(a) levels in serum of type 2 diabetes patients with or without microvascular complications were also markedly elevated when compared with those of healthy controls (all P<0.05). Spearman rank correlation analysis revealed that the levels of miR-342-5p and miR-423-5p were significantly correlated with those of ox-LDL, ox-Lp(a), β2-GPⅠ-ox-LDL, β2-GPⅠ-Lp(a). Conclusion:The levels of miR-342-5p and miR-423-5p were significantly increased in the serum of T2DM patients with or without microvascular complications, which were significantly associated with oxidized lipoprotein. The elevated serum miR-342-5p and miR-423-5p combined with oxidized lipoprotein can be used as novel biomarkers for potential auxiliary diagnosis of T2DM patients and T2DM patients with microvascular complications.

    参考文献
    相似文献
    引证文献
引用本文

蔡加炉,王成,牛冬梅,徐新纯,张辰宇,张春妮,汪俊军.2型糖尿病及其微血管并发症患者血清miR-342-5p和miR-423-5p水平测定及临床意义[J].临床检验杂志,2015,(1):24-28

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2014-10-21
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2015-02-12
  • 出版日期:
文章二维码
您是第位访问者  苏ICP备13058113号-3
苏公网安备32010202012004号
主管单位:江苏省医学会  出版单位:临床检验杂志
单位地址:江苏省南京市中央路42号  邮编:210008
电话:025-83620683 E-MAIL:lcjyzz@163.com
技术支持:北京勤云科技发展有限公司